{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:28:27Z","timestamp":1772537307876,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.anndiagpath.2020.151516","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T01:55:23Z","timestamp":1586742923000},"page":"151516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Pediatric clear cell meningioma involving the middle cranial fossa in the context of NF2 and SMARCE1 mutations"],"prefix":"10.1016","volume":"46","author":[{"given":"Diane M.","family":"Libert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Prayson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2020.151516_bb0005","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","article-title":"Histological classification and molecular genetics of meningiomas","volume":"5","author":"Riemenschneider","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0015","series-title":"WHO classification of tumours of the central nervous system","volume":"1","author":"Louis","year":"2016"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0020","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s00701-011-1052-z","article-title":"Intracranial clear cell meningioma: a clinicopathologic study of 15 cases","volume":"153","author":"Chen","year":"2011","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11060-006-9237-7","article-title":"Clear cell meningioma, an uncommon variant of meningioma: a clinicopathologic study of nine cases","volume":"81","author":"Jain","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00000478-199505000-00001","article-title":"Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma","volume":"19","author":"Zorludemir","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0035","doi-asserted-by":"crossref","first-page":"e880","DOI":"10.1016\/j.wneu.2017.12.173","article-title":"Clinical features, treatment, and prognostic factors of 56 intracranial and intraspinal clear cell meningiomas","volume":"111","author":"Tao","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0040","first-page":"130","article-title":"MR imaging features of clear-cell meningioma with diffuse leptomeningeal seeding","volume":"21","author":"Lee","year":"2000","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0045","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00381-012-1840-7","article-title":"Intracranial clear cell meningioma in two children with blood relations: two case reports and literature review","volume":"28","author":"Li","year":"2012","journal-title":"Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0050","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/his.13135","article-title":"SMARCE1 mutation screening in classification of clear cell meningiomas","volume":"70","author":"Smith","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000113112","article-title":"Clinical features and treatment of meningiomas in children: report of 12 cases and literature review","volume":"44","author":"Liu","year":"2008","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0060","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00381-012-1759-z","article-title":"Pediatric meningiomas in The Netherlands 1974\u20132010: a descriptive epidemiological case study","volume":"28","author":"Thuijs","year":"2012","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0065","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S1470-2045(11)70275-3","article-title":"Meningiomas in children and adolescents: a meta-analysis of individual patient data","volume":"12","author":"Kotecha","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0070","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s10024-005-0119-3","article-title":"Clear cell meningioma: case report and review of the literature","volume":"8","author":"Oviedo","year":"2005","journal-title":"Pediatr Dev Pathol Off J Soc Pediatr Pathol Paediatr Pathol Soc"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3171\/2008.10.17668","article-title":"Pediatric spinal clear cell meningioma: case report","volume":"3","author":"Colen","year":"2009","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0080","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s00381-015-2782-7","article-title":"A five year-old child with clear cell petro-clival meningioma: case report with clinical and histopathological long-term follow-up","volume":"31","author":"Juratli","year":"2015","journal-title":"Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10048-015-0472-y","article-title":"A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening","volume":"17","author":"Gerkes","year":"2016","journal-title":"Neurogenetics"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0090","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/path.4427","article-title":"Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas","volume":"234","author":"Smith","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/1793-5482.151520","article-title":"Clear cell meningioma in a child: a case report and review of literature","volume":"10","author":"Kumar","year":"2015","journal-title":"Asian J Neurosurg"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3348\/kjr.2002.3.2.125","article-title":"Clear-cell meningioma: CT and MR imaging findings in two cases involving the spinal canal and cerebellopontine angle","volume":"3","author":"Yu","year":"2002","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","article-title":"Pathological classification and molecular genetics of meningiomas","volume":"99","author":"Mawrin","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cancergen.2015.02.003","article-title":"Germline and somatic mutations in meningiomas","volume":"208","author":"Smith","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0115","first-page":"827","article-title":"Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma","volume":"146","author":"Wellenreuther","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ng.2552","article-title":"Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas","volume":"45","author":"Smith","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0125","doi-asserted-by":"crossref","first-page":"7953","DOI":"10.1128\/MCB.25.18.7953-7965.2005","article-title":"The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene","volume":"25","author":"Wang","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0130","author":"Reference GH"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jmg.33.1.2","article-title":"Molecular genetics of neurofibromatosis type 1 (NF1)","volume":"33","author":"Shen","year":"1996","journal-title":"J Med Genet"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jmg.36.3.197","article-title":"A clinical study of type 1 neurofibromatosis in north West England","volume":"36","author":"McGaughran","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0145","first-page":"641","article-title":"Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function","volume":"14","author":"Johnson","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0150","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00401-018-1899-7","article-title":"DMD genomic deletions characterize a subset of progressive\/higher-grade meningiomas with poor outcome","volume":"136","author":"Juratli","year":"2018","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0155","first-page":"66","article-title":"Meningiomas of the pediatric skull base: a review","volume":"76","author":"Gump","year":"2015","journal-title":"J Neurol Surg Part B Skull Base"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0160","first-page":"422","article-title":"Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma","volume":"18","author":"Prayson","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol AIMM"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0165","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.anndiagpath.2006.03.007","article-title":"Frontotemporal clear cell meningioma. Report of 3 cases","volume":"11","author":"Tena-Suck","year":"2007","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151516_bb0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S0317167100120311","article-title":"Extradural middle fossa approach to a clear cell meningioma in a child","volume":"36","author":"King","year":"2009","journal-title":"Can J Neurol Sci J Can Sci Neurol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420300575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420300575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:32:20Z","timestamp":1761078740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420300575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":34,"alternative-id":["S1092913420300575"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151516","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric clear cell meningioma involving the middle cranial fossa in the context of NF2 and SMARCE1 mutations","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151516"}}